Skip to main content
TipRanks
Go Ultimate75% OFF

Kintor Pharmaceutical Ltd (9939) Ratios

3 Followers

Kintor Pharmaceutical Ltd Ratios

HK:9939's free cash flow for Q2 2026 was ¥0.00. For the 2026 fiscal year, HK:9939's free cash flow was increased by ¥49.99M and operating cash flow was ¥-49.99M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio0.431.032.104.746.94
Quick Ratio0.341.022.102.845.35
Cash Ratio0.270.881.982.724.23
Solvency Ratio-1.05-0.62-2.55-1.68-2.01
Operating Cash Flow Ratio-1.30-1.19-1.72-0.00-0.00
Short-Term Operating Cash Flow Coverage-1.95-1.78-3.41-0.01-0.14
Net Current Asset Value¥ -103.01M¥ -49.32M¥ 61.44M¥ 947.92M¥ 1.11B
Leverage Ratios
Debt-to-Assets Ratio0.250.260.290.140.08
Debt-to-Equity Ratio0.470.450.550.190.10
Debt-to-Capital Ratio0.320.310.360.160.09
Long-Term Debt-to-Capital Ratio0.000.060.230.110.08
Financial Leverage Ratio1.871.751.901.371.25
Debt Service Coverage Ratio-1.60-1.06-8.49-8.94-83.80
Interest Coverage Ratio-52.00-15.58-109.31-115.37-336.65
Debt to Market Cap0.110.340.390.080.04
Interest Debt Per Share0.200.330.610.780.46
Net Debt to EBITDA-0.370.110.180.610.93
Profitability Margins
Gross Profit Margin24.60%-94.60%0.00%0.00%100.00%
EBIT Margin-527.63%-2919.94%0.00%0.00%-2452.75%
EBITDA Margin-426.01%-2567.40%0.00%0.00%-2422.05%
Operating Profit Margin-611.29%-2891.36%0.00%0.00%-2452.75%
Pretax Profit Margin-621.01%-3105.48%0.00%0.00%-2460.04%
Net Profit Margin-612.29%-3105.84%0.00%0.00%-2460.04%
Continuous Operations Profit Margin-612.29%-3105.84%0.00%0.00%-2460.04%
Net Income Per EBT98.59%100.01%99.25%100.11%100.00%
EBT Per EBIT101.59%107.41%100.91%100.93%100.30%
Return on Assets (ROA)-58.69%-30.15%-122.04%-46.44%-40.72%
Return on Equity (ROE)-109.54%-52.81%-231.56%-63.83%-50.88%
Return on Capital Employed (ROCE)-93.65%-41.49%-164.35%-54.38%-45.43%
Return on Invested Capital (ROIC)-66.83%-31.33%-137.83%-51.32%-45.20%
Return on Tangible Assets-85.64%-42.41%-147.28%-53.42%-41.19%
Earnings Yield-25.27%-39.57%-166.38%-29.14%-23.59%
Efficiency Ratios
Receivables Turnover8.320.300.000.000.00
Payables Turnover0.770.250.990.270.00
Inventory Turnover2.044.390.000.040.00
Fixed Asset Turnover0.210.030.000.001.31
Asset Turnover0.100.010.000.000.02
Working Capital Turnover Ratio-0.970.040.000.000.03
Cash Conversion Cycle-252.93-178.40-368.548962.411124038.43
Days of Sales Outstanding43.891215.500.000.001124038.43
Days of Inventory Outstanding179.1883.090.0010301.570.00
Days of Payables Outstanding475.991476.99368.541339.160.00
Operating Cycle223.061298.590.0010301.571124038.43
Cash Flow Ratios
Operating Cash Flow Per Share-0.37-0.46-0.90-0.00-0.00
Free Cash Flow Per Share-0.37-0.47-0.91-0.00-0.00
Dividend Paid and CapEx Coverage Ratio-228.76-118.50-142.34-34.99-13.79
Capital Expenditure Coverage Ratio-228.76-118.50-142.34-34.99-13.79
Operating Cash Flow Coverage Ratio-1.91-1.50-1.53-0.00-0.01
Operating Cash Flow to Sales Ratio-5.06-39.820.000.00-0.03
Free Cash Flow Yield-20.97%-51.16%-61.21%-0.03%-0.03%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-4.00-2.53-0.60-3.43-4.24
Price-to-Sales (P/S) Ratio24.2378.480.000.00104.29
Price-to-Book (P/B) Ratio4.331.331.392.192.16
Price-to-Free Cash Flow (P/FCF) Ratio-4.77-1.95-1.63-3312.53-3166.04
Price-to-Operating Cash Flow Ratio-4.79-1.97-1.65-3407.20-3395.62
Price-to-Earnings Growth (PEG) Ratio-0.180.030.25-0.48-0.10
Enterprise Value Multiple-6.06-2.94-0.42-2.82-3.38
Enterprise Value843.67M377.99M446.02M2.70B2.80B
EV to EBITDA-6.06-2.94-0.42-2.82-3.38
EV to Sales25.8175.600.000.0081.79
EV to Free Cash Flow-5.08-1.88-1.14-2727.24-2482.81
EV to Operating Cash Flow-5.10-1.90-1.15-2805.18-2662.84
Tangible Book Value Per Share0.170.340.723.264.58
Shareholders’ Equity Per Share0.410.681.073.974.64
Tax and Other Ratios
Effective Tax Rate-0.01-0.000.01-0.000.00
Revenue Per Share0.070.010.000.000.10
Net Income Per Share-0.44-0.36-2.47-2.53-2.36
Tax Burden0.991.000.991.001.00
Interest Burden1.181.061.000.981.00
Research & Development to Revenue2.6715.630.000.000.02
SG&A to Revenue1.8317.680.000.001.31
Stock-Based Compensation to Revenue0.00-1.850.000.000.00
Income Quality0.851.280.361.012.04

Currency in CNY